Nymox Pharmaceutical Corp (NYMX): James George Robinson , director of Nymox Pharmaceutical Corp purchased 22,500 shares on Jun 22, 2016. The Insider buying transaction was reported by the company on Jun 24, 2016 to the Securities and Exchange Commission. The shares were purchased at $2.97 per share for a total value of $66,800.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 13, 2016, James George Robinson (director) purchased 28,010 shares at $2.32 per share price.
Nymox Pharmaceutical Corporation: On Friday, Jun 24, 2016 heightened volatility was witnessed in Nymox Pharmaceutical Corporation which led to swings in the share price. The shares opened for trading at $2.78 and hit $3.23 on the upside , eventually ending the session at $3.16, with a gain of 8.59% or 0.25 points. The heightened volatility saw the trading volume jump to 5,67,622 shares. The 52-week high of the share price is $4.37 and the company has a market cap of $142 M . The 52-week low of the share price is at $1.13.